Sepsis affects millions of people worldwide each year. It occurs when a normal human immune response to a bacterial, viral or fungal infection becomes dysfunctional and triggers widespread inflammation that results in severe tissue damage that leads to organ failure, shock, and death. Sepsis, requires immediate treatment and has a high readmission rate for survivors. It is also one of the most expensive conditions to treat. In 2013, there were more than 1.6 million cases of sepsis in the United States with a financial cost of more than $23 billion. Sepsis was first described in antiquity, and given its current name, by the ancient Greek physician Hippocrates. Despite its long medical history, severity, and financial burden, the causes of sepsis are not well understood, and there is no standard approach to diagnosis and treatment. The definition of sepsis, the characterization of its clinical stages, and sepsis monitoring tools have changed three times in the past 25 years, most recently in March 2016. The universal adoption of this latest definition, sepsis-3, and a screening tool, qSOFA, are currently under debate in the medical community. A means to rapidly identify and treat sepsis could reduce the five million deaths due to sepsis each year worldwide. This paper reviews the evolution of the definition of sepsis and the controversy surrounding the sepsis-3 definition and the sepsis screening tool, qSOFA.
I. Introduction
Sepsis is one of the oldest, costliest, and most devastating medical conditions in the world. Sepsis was first described in ancient Egypt almost 5,000 years ago and given its current name by the Greek physician Hippocrates about 2,400 years ago (Botero and Pérez, 2012) . In 2013, the annual financial burden of sepsis in the United States was more than $23 billion. Despite its long history and its current impact on society, sepsis as a medical condition is not well understood. The definition is under current revision Simpson, 2016; Cortés-Puch and Hartog, 2016; Abraham, 2016) ; there is no gold standard diagnostic test for sepsis, nor is there a universally adopted treatment . Along with revising the definition, there is a search for the best screening tool to identify sepsis. A medical task force has utilized the recent availability of large datasets of patients to compare and validate several screening tools for sepsis. These tools were used to explore more than one million patient electronic healthcare records (EHR), which had a known number of patients with sepsis . This use of a data science approach to validating a screening tool for sepsis is a promising area of research. Here we describe the severity of sepsis, its evolving definition, and the screen tool, qSOFA.
A. The Severity of Sepsis
Sepsis is a significant cause of healthcare costs and mortality rates. Worldwide, an estimated 31.5 million people are treated each year for sepsis of which 5.3 million end up dying from sepsis (Fleischmann, et al., 2016) . In the United States, there are about 1.6 million cases of sepsis each year with more than 258,000 deaths, which averages to one person dying of sepsis every two minutes (Sepsis Alliance, 2016). The financial cost of treating sepsis is staggering. The 2015 Healthcare Cost and Utilization Project (HUCP) Statistical Brief places sepsis as the most expensive condition treated in US hospitals at $23.7 billion (Torio and Andrews, 2015) . Sepsis accounts for 40 percent of all ICU costs in the United States, and the average cost for treatment of ICU patients with sepsis is six times greater than that for ICU patients that do not have sepsis. Additionally, patients discharged after a serious bout of sepsis have a 62 percent readmission rate (Sutton & Friedman, 2013; Sepsis Alliance, 2014) . This information on the severity of sepsis is summarized in figure 1. Research has shown early detection of sepsis is essential in saving lives and reducing cost (Shore, et al., 2007; Jones, et al., 2015; Singer et al., 2016) . The Sepsis Alliance estimate that 80% of deaths due to sepsis could be prevented with rapid diagnosis and treatment (Sepsis Alliance, 2016).
II. The Evolving Definition and Monitoring of Sepsis
The definition of sepsis has shifted over time. Originally sepsis was thought to be an internal rotting or decaying. This was due to the smell of those afflicted (Funk, et al., 2009 ).
Hippocrates applied the Greek word for decay-sepsis, meaning decay or to rot-to this medical condition. The development of medical hygiene and the germ theory in the late 1800s by Louis Pasteur, Joseph Lister, and Robert Kock helped change the viewpoint of sepsis from internal decay to originating from a harmful microorganism. In 1914, Hugo Schottmüller laid the foundation for a modern definition of sepsis when he wrote, "Sepsis is present if a focus has developed from which pathogenic bacteria, constantly or periodically, invade the blood stream in such a way that this causes subjective and objective symptoms" (Rittirsch et al., 2008) .
As sepsis became more common in ICUs, the role of the patient's immune response became a greater focal point (Bone et al., 1992) . In 1992, a conference was held by the Society of Critical Care Medicine and the American College of Chest Physicians to address the lack of consensus regarding the definition of sepsis and the difficulties this created in studies and treatment. This conference and its outcomes are now referred to as sepsis-1. This was followed by sepsis-2 in 2002 and sepsis-3 in 2016.
Key outcomes from the sepsis-1 conference (Bone et al., 1992 ):
• The establishment of the term "systemic inflammatory response syndrome" (SIRS) was considered a clinical stage of sepsis.
• Key definitions for sepsis were established (see below).
• No definable presence of bacterial infection was required to diagnose sepsis.
• The terms "severe sepsis" and "septic shock" were introduced to differentiate degrees of severity.
Key definitions established at the sepsis-1 conference:
• Sepsis results from a host's systemic inflammatory response syndrome (SIRS) to infection.
• Severe sepsis is sepsis associated with organ dysfunction, hypoperfusion, or hypotension.
• Septic shock is sepsis-induced hypotension persisting despite adequate fluid resuscitation.
The sepsis-1 conference also established four clinical stages or steps. Each stage had specific clinical indicators (see figure 2) as well their challenges for healthcare providers. The first stage is SIRS (systemic inflammatory response syndrome) and is defined by the presence of at least two of the following four indicators: (1) a body temperature above 38.0° C or below 36.0° C; (2) a heart rate above 90 beats/minute; (3) a respiratory rate above 20 breaths per minute; (4) a white blood cell count higher than 12,000 or lower than 4,000 cells per microliter.
If an infection is confirmed or suspected, then the diagnosis changes from SIRS to sepsis. As sepsis progresses from one stage to another, there is a corresponding increase in the mortality rate with septic shock having the highest. Figure 2 lists the 30-day mortality rates published for SIRS and sepsis (Rangel-Fausto et al., 1995) and those published for severe sepsis and septic shock (Schoenberg, et al., 1998) . • keeping the sepsis-1 definition, but recognize it has limitations;
• expanding the list of diagnostic criteria for sepsis; and
• recognizing the separate characteristics or stages of sepsis designated by the acronym PIRO: predisposition, infection, response to the infectious challenge, and organ dysfunction (Levy et al., 2003) . The expanded list of diagnostic criteria of sepsis included 21 bedside or laboratory tests designed to indicate either inflammation or organ dysfunction.
B. Sepsis Early Warning Systems
Since the introduction of sepsis-2, there has been an increase in the use of organ failure or mortality scoring systems also known as early warning score (EWS) systems. These EWS systems are used in most ICUs as a method to triage the severity of critically ill patients. They are bedside evaluations designed to provide a likely mortality rate within 28 to 30 days. Several of these EWS systems were developed in line with the sepsis-1 and sepsis-2 definitions.
The EWS systems used in ICUs and adopted to monitor sepsis include:
• APACHE II (the Acute Physiology and Chronic Health Evaluation II) Score, introduced in 1985, • MEWS (the Modified Early Warning Score), developed in 1999 as a modification of the Morgan's Early Warning Score (Morgan et al., 1997 ).
• MEDS (see figure 3 and 4) , and • SOFA (the Sepsis-related Organ Failure Assessment) (Vincent, et al., 1996) .
To illustrate a EWS, the scores used to determine a patient's mortality rate using MEDS is shown below. Figure 3 is the checklist used to determine the score and figure 4 shows the predicted mortality rate based on the score. These EWS systems has helped identify the progress of sepsis in patients and allowed ICUs to determine where to deploy their resources and staff. The use of EWS is significant in the monitoring of sepsis, especially in the ICUs where up to 40 percent of the cost can be due to treating patients with sepsis.
Along with these early warning systems, sepsis awareness campaigns have been shown to be beneficial. The Society of Critical Care Medicine and the European Society of Intensive Care Medicine provide direction for the Surviving Sepsis Campaign, which, in 2009, helped achieve a 25 percent reduction in sepsis mortality through awareness and education about sepsis, especially among healthcare providers (Dellinger et al., 2008) . The Sepsis Alliance, a voluntary health organization founded in 2004, is raising awareness of sepsis among healthcare providers and the general public. This included launching sepsis awareness month, September, helping launch the global sepsis alliance, the heroes of sepsis celebration, and designating September 13 as world sepsis day. The heroes of sepsis celebration focuses on recognizing organizations and individuals that have contributed to advancing sepsis research and education. This event brings together survivors with healthcare providers. Damian Mingle, one of the authors of this paper, was a finalist for the 2016 hero of sepsis.
C. Sepsis-3 (2016)
In 2014, the European Society of Intensive Care Medicine (ESICM) and the Society of Critical Care Medicine (SCCM) convened a task force of 19 critical care, infectious disease, surgical, and pulmonary specialists with the aim to update the definitions and clinical criteria identifying the "septic patient." The sepsis-3 task force recognized sepsis as more complex than infection and inflammation and defined sepsis as a "life-threatening organ dysfunction due to a dysregulated host response to infection." In this new definition (sepsis-3), the host response resulting in organ failure from an infection is stressed while the inflammation stage known as SIRS in sepsis-1 and -2 has been removed. The task force included advances made in understanding the pathology, management, and epidemiology of sepsis as well as an analysis of over one million patients. The results published in the February 2016 issue of JAMA, the Journal of the American Medical Association, reduced the clinical stages in sepsis from the four described in figure 2 to the last two stages . The previous of clinical stage known as severe sepsis is now used to define sepsis. Sepsis is now defined as "a life-threatening organ dysfunction caused by a dysregulated host response to infection." . The key features and new definition for sepsis are in figure 5 below. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Septic shock is a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated with a greater risk of mortality than with sepsis alone.
To determine which early warning signal to recommend, the sepsis-3 task force compared a variety of EWS systems used to monitor sepsis. The results showed that qSOFA EWS systems was similar to the accuracy to most EWS, but is easier to use and more accurate in locations outside of or prior to admissions into the ICU. Figure 6 has the qSOFA scoring system. A qSOFA score ≥2 suggests a high risk of poor outcome and an indication that these patients have sepsis and should have their lactate levels tested for evidence of organ dysfunction. To validate qSOFA as a screening and monitoring tool for sepsis, scores were applied to a large set of electronic health record data which contained known patients with sepsis. The dataset used contained the electronic health record data of 1.3 million encounters from January 1, 2010, to December 31, 2012, at 12 community and academic hospitals within the University of Pittsburgh Medical Center health system in southwestern Pennsylvania were used for this comparison. The predictive validity of qSOFA and other EWS tool were compared by plotting the area under the receiver operating characteristic curve (AUROC). It was the recent availability of a large set of electronic health record data made this study possible.
D. Controversy surrounding Sepsis-3 definition
The definition for sepsis developed by the sepsis-3 task force and qSOFA have not been universally adopted. Several papers and letters to the JAMA editor has raised concerns (Sprung & Reinhart, 2016; Kleinpell, et al, 2016; Abraham, E., 2016) . A few of the major concerns about the sepsis-3 definition include:
• A focus on adult patients without including newborn and pediatric patients.
• Research generated from patients in the United States and Europe but not from economically poorer countries.
• A task force without experts from emergency medicine and other important groups.
• The change in the clinical stages of sepsis, making comparisons with prior research about sepsis difficult. The past 25-year body of sepsis research focused on four clinical stages of sepsis and the new definition changes this to two clinical stages.
• Too much reliance on qSOFA to diagnose sepsis.
• A lack of endorsement by all societies including the Latin American Sepsis Institute, American College of Chest Physicians, and American College of Emergency Physicians.
III. Area of Promising Research in Sepsis
While there remains controversy surrounding the definition of sepsis, key advances in research continue. One of the areas of promise is using data science approaches to mine insights and knowledge from large databases of electronic healthcare records. This was done to verify and test qSOFA and other EWS. Several hospitals are now utilizing computational means to monitor patients within the ICU. The availability of large sets of digital healthcare records that can be analyzed with data science approaches is able to provide a new approach to the rapid identification and treatment of sepsis. (Calvert et al., 2016; Henry et al., 2016) . If sepsis can be rapidly detected and treated, the financial cost and patient suffering will decrease.
MIMIC (Medical

IV. Summary
According to the sepsis-3 definition task force, the process of defining sepsis remains a work in progress: "As is done with software and other coding updates, the task force recommends that the new definition be designated Sepsis-3, with the 1991 and 2001 iterations being recognized as Sepsis-1 and Sepsis-2, respectively, to emphasize the need for future iterations." .
The evolving definition of sepsis can be seen as four major updates to its original definition with needs for future iterations. The original definition began in antiquity when sepsis was named and defined by the rotting smell of its victims. This was updated in 1917 when the definition focused on infection as the trigger for sepsis. In 1992 the sepsis' definition was updated again and this time the focus was on the patient's systemic inflammation response (sepsis-1). In 2016, sepsis' definition was updated a fourth time to focus on organ dysfunction. The lack of universal adaption of the sepsis-3 definition suggests its definition will evolve again as a future iteration suggested by the sepsis-3 task force.
This updating or evolving definition reveals several important factors contributing to the medical condition known as sepsis. These include (1) the pathogen that triggers sepsis; (2) the patient's immune response to the pathogen; and (3) the patient's medical history and condition at the time of sepsis. It is the interplay between these factors that make each case of sepsis to be somewhat unique to the individual and their current medical condition.
In addition to its evolving definition, sepsis is a challenge for healthcare providers to diagnosis and treat. This challenges include:
• The lack of a gold standard for identification and treatment.
• Symptoms of other disorders mask that of sepsis (see appendix A for list).
• A low percentage of patients have sepsis (~2% of emergency room patients have sepsis).
• The rapidly progression of sepsis to a fatal outcome • A high mortality rate Sepsis is often not suspected by heath care providers. The clinical symptoms used in diagnosing sepsis (raised temperature, increased breathing rate, and mental alertness) do not rule out other common disorders. In fact, a number of disorders appear as sepsis (see appendix A). Most of these disorders are seen in a higher percentage of patients entering emergency rooms than sepsis. As a result of these challenges, sepsis is often diagnosed too late to save the patient. Although awareness campaigns and ICU early warning systems have been shown to be beneficial.
The rapid identification and treatment of sepsis is critical. In spite of these challenges, several investigators consider sepsis reversible and preventable (Levy, et al., 2004; Marshall, 2015) . If sepsis can be rapidly detected and treated, the financial cost and patient suffering will decrease. More exploration of large electronic patient databases involving patients with sepsis, such as MIMIC, using data science approaches are needed. Data science approaches, such as machine learning, predictive analytics, and data mining, are beginning to be applied to difficult healthcare problems (Holzinger and Jurisica, 2014, Chennamsetty, et al., 2015) The result of which should lead to insights into the best ways to identify, monitor and treat for patients with sepsis.
